Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Pharmacokinetics and Metabolic Activation of Capecitabine
This study is currently recruiting participants.
Verified April 2012
by Arbeitsgemeinschaft medikamentoese Tumortherapie
Study NCT01579357 Information provided by Arbeitsgemeinschaft medikamentoese Tumortherapie
First Received on March 29, 2012. Last Updated on April 17, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Metastatic Colorectal Cancer
Additional conditions recognized in this trial
Colorectal Neoplasms
More general conditions related to this trial
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Neoplasms
Neoplasms by Site
Rectal Diseases
Interventions listed in this trial
blood samples
Additional drug interventions recognized in this trial
Capecitabine
Cetuximab
Oxaliplatin
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Arbeitsgemeinschaft medikamentoese Tumortherapie
Back to top of Main Content